GB8725812D0 - Antibodies - Google Patents

Antibodies

Info

Publication number
GB8725812D0
GB8725812D0 GB878725812A GB8725812A GB8725812D0 GB 8725812 D0 GB8725812 D0 GB 8725812D0 GB 878725812 A GB878725812 A GB 878725812A GB 8725812 A GB8725812 A GB 8725812A GB 8725812 D0 GB8725812 D0 GB 8725812D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB878725812A
Other versions
GB2197323A (en
GB2197323B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Development Corp UK
National Research Development Corp of India
Original Assignee
National Research Development Corp UK
National Research Development Corp of India
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Development Corp UK, National Research Development Corp of India filed Critical National Research Development Corp UK
Publication of GB8725812D0 publication Critical patent/GB8725812D0/en
Publication of GB2197323A publication Critical patent/GB2197323A/en
Application granted granted Critical
Publication of GB2197323B publication Critical patent/GB2197323B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
GB8725812A 1986-11-05 1987-11-04 Antibodies Expired - Fee Related GB2197323B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868626413A GB8626413D0 (en) 1986-11-05 1986-11-05 Antibodies

Publications (3)

Publication Number Publication Date
GB8725812D0 true GB8725812D0 (en) 1987-12-09
GB2197323A GB2197323A (en) 1988-05-18
GB2197323B GB2197323B (en) 1990-10-31

Family

ID=10606822

Family Applications (2)

Application Number Title Priority Date Filing Date
GB868626413A Pending GB8626413D0 (en) 1986-11-05 1986-11-05 Antibodies
GB8725812A Expired - Fee Related GB2197323B (en) 1986-11-05 1987-11-04 Antibodies

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB868626413A Pending GB8626413D0 (en) 1986-11-05 1986-11-05 Antibodies

Country Status (5)

Country Link
EP (1) EP0293405A1 (en)
JP (1) JPH01501201A (en)
AU (1) AU616870B2 (en)
GB (2) GB8626413D0 (en)
WO (1) WO1988003566A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2621127B1 (en) * 1987-09-30 1992-01-31 Roussy Inst Gustave MONOCLONAL ANTIBODIES RECOGNIZING A GAMMA CHAIN EPITOPE OF HUMAN T CELL SURFACE RECEPTORS, LINE OF HYBRIDOMA CELLS PRODUCING THE SAME, AND USE OF THIS MONOCLONAL ANTIBODY
EP0334300A1 (en) * 1988-03-21 1989-09-27 Neorx Corporation The use of monoclonal antibodies and conjugates thereof as signals to direct sensitized effector cells to tumor sites
US5223426A (en) 1988-12-15 1993-06-29 T Cell Sciences, Inc. Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor
US5766947A (en) * 1988-12-14 1998-06-16 Astra Ab Monoclonal antibodies reactive with an epitope of a Vβ3.1 variable region of a T cell receptor
US5897861A (en) * 1989-06-29 1999-04-27 Medarex, Inc. Bispecific reagents for AIDS therapy
EP0739904A1 (en) * 1989-06-29 1996-10-30 Medarex, Inc. Bispecific reagents for aids therapy
US5858363A (en) * 1990-07-20 1999-01-12 Pharmacia & Upjohn Ab Target specific antibody-superantigen conjugates and their preparation
ES2094231T3 (en) * 1990-07-20 1997-01-16 Pharmacia & Upjohn Ab CONJUGATES OF SPECIFIC ANTIBODIES OF AN TARGET AND ITS PREPARATION.
JP3105629B2 (en) † 1991-04-23 2000-11-06 サングスタット メディカル コーポレイション Cell activity regulating conjugates of members of specific binding pairs
US5587458A (en) * 1991-10-07 1996-12-24 Aronex Pharmaceuticals, Inc. Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
US5945311A (en) * 1994-06-03 1999-08-31 GSF--Forschungszentrumfur Umweltund Gesundheit Method for producing heterologous bi-specific antibodies
DE4419399C1 (en) * 1994-06-03 1995-03-09 Gsf Forschungszentrum Umwelt Process for the preparation of heterologous bispecific antibodies
WO2001074382A1 (en) 2000-03-31 2001-10-11 Purdue Research Foundation Method of treatment using ligand-immunogen conjugates
JP5168538B2 (en) * 2007-05-24 2013-03-21 アボットジャパン株式会社 Antibody-antibody conjugates and application to diagnostic antibodies
KR102010827B1 (en) 2009-06-26 2019-08-14 리제너론 파마슈티칼스 인코포레이티드 Readily isolated bispecific antibodies with native immunoglobulin format
RU2608640C2 (en) 2010-08-16 2017-01-23 Новиммун С.А. Methods for generation of multispecific and multivalent antibodies
ES2872081T3 (en) 2011-08-05 2021-11-02 Regeneron Pharma Humanized Universal Light Chain Mice
AR101262A1 (en) 2014-07-26 2016-12-07 Regeneron Pharma PURIFICATION PLATFORM FOR Bispecific Antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
ES521370A0 (en) * 1982-04-12 1985-04-16 Hybritech Inc A PROCEDURE FOR OBTAINING A POLYDOMA.

Also Published As

Publication number Publication date
EP0293405A1 (en) 1988-12-07
JPH01501201A (en) 1989-04-27
WO1988003566A1 (en) 1988-05-19
AU616870B2 (en) 1991-11-14
AU8156887A (en) 1988-06-01
GB2197323A (en) 1988-05-18
GB2197323B (en) 1990-10-31
GB8626413D0 (en) 1986-12-03

Similar Documents

Publication Publication Date Title
GB2197322B (en) Antibodies
GB2209757B (en) Altered antibodies
GB8408193D0 (en) Antibodies
GB2197323B (en) Antibodies
GB8608068D0 (en) Monoclonal antibodies
GB8614084D0 (en) Immunoassay
GB8624899D0 (en) Monoclonal antibodies
GB8621910D0 (en) Monoclonal antibodies
GB8505487D0 (en) Antibodies
GB8715347D0 (en) Monoclonal antibodies
GB8726230D0 (en) Antibodies
GB8616174D0 (en) Monoclonal antibodies
GB8629740D0 (en) Immunoassay
GB8710074D0 (en) Antibodies
GB8610203D0 (en) Monoclonal antibodies
GB8610202D0 (en) Monoclonal antibodies
GB8619998D0 (en) Antibodies
GB8620589D0 (en) Antibodies
GB8623088D0 (en) Antibodies
GB8610318D0 (en) Antibodies
GB8621240D0 (en) Antigens
GB2215725B (en) Monoclonal antibodies
GB8708648D0 (en) Antibodies
GB8729520D0 (en) Antibodies
GB8506372D0 (en) Antibodies

Legal Events

Date Code Title Description
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19931104